Tate & Lyle and Lipid Nutrition Partner to Develop New ENRICH Ingredient Systems with PinnoThin, Clarinol and Marinol

24/10/07 Tate & Lyle and Lipid Nutrition announced that they have entered into an exclusive new partnership. Tate & Lyle will develop new ENRICH ingredient systems for soups, sauces and dressings which incorporate Lipid Nutrition’s PinnoThin pine nut oil, Clarinol conjugated linoleic acid (CLA) and Marinol fish oils and powders. The agreement means that Tate & Lyle will have the exclusive rights to market PinnoThin, Clarinol and Marinol in Europe, the Middle East and Africa in the soups, sauces and dressings category. In return Lipid Nutrition will gain access to Tate & Lyle’s technical knowledge, applications support and extensive customer base in this category.

Netherlands-based Lipid Nutrition is a producer of specialised lipids, which improve and maintain health and well-being and has developed and patented a unique and 100 per cent natural product called PinnoThin. PinnoThin has been shown to suppress the desire to eat by promoting a feeling of satiety (fullness) and helping to reduce the excessive consumption of calories. It is suitable for vegetarians and can be used in a range of applications including dairy, beverages, spreads, bakery and confectionery. Appetite suppressants currently account for 13 per cent of the slimming aids market, and with obesity set to overtake smoking as the most important cause of heart disease, it is not surprising that satiety is becoming increasingly recognized as a potential major contributor to successful weight management.

Clarinol concentrated CLA has been shown to improve body composition by reducing body fat and increase lean muscle mass in the specific areas of the body where fat loss is most desired.

The range of Marinol naturally concentrated fish oils and powders offer opportunities for enrichment of omega-3 fatty acids via functional foods for heart and brain health. It offers different EPA and DHA[1] ratios to provide the specific health benefits. This makes it possible to enhance and customise a wide variety of food products.

Tate & Lyle ENRICH was launched as part of Tate & Lyle’s CORE offering earlier this year, to enable food and beverage manufacturers to create products that are packed with additional nutrients but taste as good as regular brands. The service focuses on three main areas - Digestive Health and Immunity, Obesity and Weight Management and Children’s Health.

James Blunt, Tate & Lyle’s Product Management Director Europe, said, “Our partnership with Lipid Nutrition is an exciting development for Tate & Lyle’s ENRICH service and our health and wellness platform overall. PinnoThin and Clarinol will be incorporated in ENRICH systems for obesity and weight management. Marinol will be used in our ENRICH concepts for children’s health and in time may open up opportunities in areas such as heart health. Our R&D teams have already started to develop a range of ENRICH prototypes with these ingredients. This means more choice for our customers and enables them to develop consumer products with a health proposition targeted to specific market segments.”

We are delighted to be working with Tate & Lyle and believe this partnership can give a huge boost to the market,” said John Kurstjens, Lipid Nutrition’s Global Marketing Manager. “Lipid Nutrition holds a leadership position with these ingredients for dietary supplements and functional foods, and this partnership provides us with a great opportunity to further extend the application areas for our innovative products.”

The first product prototype to be developed through the new partnership - Soup ENRICH - will be showcased at Food Ingredients Europe later this month (30th October – 1st November, Tate & Lyle stand no. C141 and Lipid Nutrition stand no H41).